Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ACNT · Nasdaq · United States · Chemicals & Allied Products
In shortASCENT INDUSTRIES CO. is profitable.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -9.4% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 1.2% | 25/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 1.0% | 5/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 6.72× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 8.71 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -2.8% | 9/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | -2.38× | 0/100 |
| Years with positive free cash flow (last 5) | 4 of 5 | 75/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 4 of 5 | 0/100 |
| Revenue growth volatility | 32.3% | 0/100 |
| Operating margin volatility | 12.0% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -34.1% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | -65.1% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 335 | 262 | 193 | 81 | 75 |
| Cost of revenue | 274 | 219 | 192 | 70 | 58 |
| Gross profit | 61 | 43 | 1.5 | 11 | 17 |
| Research & development | – | – | – | 0 | 0.1 |
| Selling, general & admin | 30 | 28 | 27 | 20 | 23 |
| Operating income | 27 | 15 | (37) | (11) | (7) |
| Interest expense | 1.5 | 2.7 | 4.2 | 0.4 | – |
| Pre-tax income | 25 | 12 | (41) | (11) | (5.6) |
| Income tax | 5.3 | (5.6) | (6.9) | 1.8 | 0 |
| Net income | 20 | 22 | (27) | (14) | 0.9 |
| Diluted EPS | $2.14 | $2.12 | −$2.63 | −$1.35 | $0.09 |
| Diluted shares (millions) | 9.5 | 10 | 10 | 10 | 9.6 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
8.71 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
7/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 4, 2026